The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy

BJU International

Volumn 102, Issue 7, 2008, Pages 786-792

  Zacharakis, Evangelos ^a   Ahmed, Hashim U ^a   Ishaq, Ayesha ^a   Scott, Rebecca ^a   Illing, Rowland ^b,c   Freeman, Alex ^c   Allen, Clare ^c   Emberton, Mark ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

HIFU; Prostate cancer; Radiotherapy; Recurrent; Sonablate 500; Transrectal

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANESTHESIA COMPLICATION; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PATIENT SAFETY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SALVAGE THERAPY; TISSUE NECROSIS; TREATMENT FAILURE; URETHRA FISTULA; URINARY TRACT INFECTION; URINE INCONTINENCE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 50949119163     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07775.x     Document Type: Article

References (22)

1. Shipley WU, Thames HD, Sandler HM et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999 281 : 1598 604
2. Zelefsky MJ, Kuban DA, Levy LB et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007 67 : 327 33
3. Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hamks GE. Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol 2004 171 : 1132 6
4. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005 73 : 373 9
5. Nguyen PL, D'Amico AV, Lee AK, Suh WW. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 2007 110 : 1417 28
6. Gelet A, Chapelon JY, Poissonnier L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004 63 : 625 9
7. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005 5 : 321 7
8. Chen L, ter Haar GR, Hill CR et al. Effect of blood perfusion on the ablation of liver parenchyma with high-intensity focused ultrasound. Phys Med Biol 1993 38 : 1661 73
9. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localised prostate cancer: feasibility study. J Urol 2004 171 : 2265 7
10. Illing RO, Leslie TA, Kennedy JE, Calleary JG, Ogden CW, Emberton M. Visually directed high-intensity focused ultrasound for organ confined prostate cancer: a proposed standard for the conduct of therapy. BJU Int 2006 98 : 1187 92
11. Zacharakis E, Ahmed HU, Ishaq A et al. Visually-directed primary HIFU for treating localised prostate cancer. Determinants PSA Kinetics. Urology 2007 70 (Suppl. 1 139 40
12. Ward JF, Sebo TJ, Blute ML, Zinke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 2005 173 : 1156 60
13. van der Poel HG, Beetsma DB, van Boven H, Horenblas S. Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol 2007 51 : 1565 72
14. Sanderson KM, Penson DF, Cai J et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 2006 176 : 2025 32
15. Garzotto M, Wajsman Z. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year follow-up. J Urol 1998 159 : 950 5
16. D'Amico AV, Whittington R, Malkowicz SB et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999 17 : 168 72
17. Kattan MW, Zelefsky MJ, Kupelian PA et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 2003 21 : 4568 71
18. Zagars GK, von Eschenbach AC, Ayala AG. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer 1993 72 : 1709 25
19. Izawa JI, Madsen LT, Scott SM et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002 20 : 2664 71
20. de la Taille A, Hayek O, Benson MC et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 2000 55 : 79 84
21. Amling CL, Lerner SE, Martin SK, Slezak JM, Blute ML, Zincke H. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 1999 161 : 857 63
22. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995 153 : 104 10